ACIP Recommendations: Pneumococcal Vaccine

Published in Morbidity and Mortality Weekly Report (MMWR)

The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).

CURRENT Pneumococcal vaccine recommendations

MMWR, September 12, 2024, Vol 73(36);793–798
Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
Print Version

MMWR. September 29, 2023, Vol 72(39);1072
ACIP Updates: Recommendations for Use of 20-Valent Pneumococcal Conjugate Vaccine in Children ― United States, 2023
Print Version

• See also:
  • ACIP Updates: Recommendations for the Use of 20-Valent Pneumococcal Conjugate Vaccine in Children

MMWR. September 8, 2023, Vol 72(RR-3);1–39
Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
Print Version

MMWR. September 16, 2022, Vol 71(37);1174–1181
Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Print Version

• See also:
  • ACIP-VFC Resolution

ARCHIVED historical Pneumococcal immunization publications

For your convenience, these archived publications can be used for historical and research purposes.

MMWR. January 28, 2022, Vol 71(4);109–117
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
Print version

MMWR. November 22, 2019, Vol 68(46);1069–1075
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years
Print version

MMWR. September 4, 2015, Vol 64(34);944-947
Intervals between PCV13 and PPSV23 vaccines
Print version

MMWR. September 19, 2014, Vol 63(37);822-825
Use of PCV-13 and PPSV-23 vaccine among adults aged 65 and older: recommendations of the ACIP
Print version

MMWR, June 28, 2013, Vol 62(25);521-524
Use of PCV-13 and PPSV-23 Vaccines Among Children Aged 6–18 Years with Immunocompromising Conditions
Print version

MMWR, October 12, 2012, Vol 61(40);816-819
Use of PCV13 and PPSV23 Vaccine for Adults with Immunocompromising Conditions
Print version

MMWR, June 1, 2012, Vol 61(21);394-395
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Print version

MMWR, December 10, 2010, Vo1 59(RR-11);1-18
Prevention of Pneumococcal Disease Among Infants and Children—Use of PCV13 & PPSV23
Print version

MMWR, September 3, 2010, Vol 59(34);1102-1106
Updated Recommendations for Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23)
Print version

MMWR, March 12, 2010, Vol 59(09);258-261
Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children – ACIP, 2010
Print version

MMWR, April 4, 2008, Vol 57(13);343-344
Updated Recommendation from the ACIP for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24-59 Months Who Are Not Completely Vaccinated
Print version

MMWR, September 17, 2004, Vol 53(36);851-852
Notice to Readers: Pneumococcal Conjugate Vaccine Shortage Resolved
Print version

MMWR, July 9, 2004, Vol 53(26);589-590
Notice to Readers: Updated Recommendations for Use of Pneumococcal Conjugate Vaccine: Reinstatement of the Third Dose
Print version

MMWR, March 5, 2004, Vol 53(08);177-178
Notice to Readers: Updated Recommendations on the Use of Pneumococcal Conjugate Vaccine: Suspension of Recommendation for Third and Fourth Dose
Print version

MMWR, August 8, 2003, Vol 52(31);739-740
Pneumococcal Vaccination for Cochlear Implant Candidates and Recipients: Updated Recommendations of the ACIP
Print version

MMWR, May 16, 2003, Vol 52(19);446-447
Notice to Readers: Pneumococcal Conjugate Vaccine Shortage Resolved [Includes catch-up table]
Print version

MMWR, October 18, 2002, Vol 51(41);931
Notice to Readers: Pneumococcal Vaccination for Cochlear Implant Recipients
Print version

MMWR, October 6, 2000, Vol 49(RR-09);1-38
Preventing Pneumococcal Disease Among Infants and Young Children
Print version

MMWR, April 4, 1997, Vol 46(RR-08);1-24
Prevention of Pneumococcal Disease: Recommendations of ACIP (updates to MMWR 1989)
Print version